Intraoperative electron radiotherapy (IOERT) in colorectal cancer: Updated systematic review of techniques, oncological outcomes and complications

IF 2.9 2区 医学 Q2 ONCOLOGY Ejso Pub Date : 2025-05-01 Epub Date: 2025-02-24 DOI:10.1016/j.ejso.2025.109724
Abhinav Tiwari , Sheah Lin Lee , Tom MacCabe , Michal Woyton , Charles T. West , Rohan Micklethwaite , Hideaki Yano , Malcolm A. West , Alex H. Mirnezami
{"title":"Intraoperative electron radiotherapy (IOERT) in colorectal cancer: Updated systematic review of techniques, oncological outcomes and complications","authors":"Abhinav Tiwari ,&nbsp;Sheah Lin Lee ,&nbsp;Tom MacCabe ,&nbsp;Michal Woyton ,&nbsp;Charles T. West ,&nbsp;Rohan Micklethwaite ,&nbsp;Hideaki Yano ,&nbsp;Malcolm A. West ,&nbsp;Alex H. Mirnezami","doi":"10.1016/j.ejso.2025.109724","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Intra-operative electron radiotherapy (IOERT) directly delivers a large fraction of radiation to at-risk margins during surgery. However, the precise benefit of IOERT in patients with locally advanced and locally recurrent colorectal cancer (LACC/LRCC) is unclear. This study aimed to provide an updated summary of the current evidence available regarding IOERT as part of multi-modality treatment of LACC and LRCC.</div></div><div><h3>Method</h3><div>This systematic review update was prospectively registered on PROSPERO (CRD42023438184). An electronic literature search was carried out using Ovid (MEDLINE), EMBASE, Web of Science, and the Cochrane Library databases for studies from July 2011 to April 2024. The inclusion criteria were adult patients who received IOERT as part of multi-modal treatment for LACC or LRCC. The primary outcome was overall survival (OS), disease free survival (DFS) and local control (LC) at 5 years. Secondary outcomes included post-operative complications.</div></div><div><h3>Results</h3><div>16 new studies were identified since the previous analysis, and included (study population 1912 patients) of which two were prospective. High heterogeneity prevented meta-analysis of outcomes except for 5-year OS which suggested a non-significant benefit favouring IOERT. Significant methodological concerns were identified making interpretations challenging, however patients with LACC or LRCC with an R1 resection margin showed a favourable 5-year OS (40 % and 18 % respectively) when compared to current evidence.</div></div><div><h3>Conclusion</h3><div>Although limited by a lack of appropriately conducted randomised evidence, IOERT-containing multi-modality treatment may improve oncological outcomes in LACC and LRCC patients with R1 resections.</div></div>","PeriodicalId":11522,"journal":{"name":"Ejso","volume":"51 5","pages":"Article 109724"},"PeriodicalIF":2.9000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ejso","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0748798325001520","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/24 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Intra-operative electron radiotherapy (IOERT) directly delivers a large fraction of radiation to at-risk margins during surgery. However, the precise benefit of IOERT in patients with locally advanced and locally recurrent colorectal cancer (LACC/LRCC) is unclear. This study aimed to provide an updated summary of the current evidence available regarding IOERT as part of multi-modality treatment of LACC and LRCC.

Method

This systematic review update was prospectively registered on PROSPERO (CRD42023438184). An electronic literature search was carried out using Ovid (MEDLINE), EMBASE, Web of Science, and the Cochrane Library databases for studies from July 2011 to April 2024. The inclusion criteria were adult patients who received IOERT as part of multi-modal treatment for LACC or LRCC. The primary outcome was overall survival (OS), disease free survival (DFS) and local control (LC) at 5 years. Secondary outcomes included post-operative complications.

Results

16 new studies were identified since the previous analysis, and included (study population 1912 patients) of which two were prospective. High heterogeneity prevented meta-analysis of outcomes except for 5-year OS which suggested a non-significant benefit favouring IOERT. Significant methodological concerns were identified making interpretations challenging, however patients with LACC or LRCC with an R1 resection margin showed a favourable 5-year OS (40 % and 18 % respectively) when compared to current evidence.

Conclusion

Although limited by a lack of appropriately conducted randomised evidence, IOERT-containing multi-modality treatment may improve oncological outcomes in LACC and LRCC patients with R1 resections.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
结直肠癌术中电子放疗(IOERT):技术、肿瘤预后和并发症的最新系统综述
背景术中电子放射治疗(IOERT)在手术中直接向危险边缘提供很大一部分辐射。然而,IOERT在局部晚期和局部复发性结直肠癌(LACC/LRCC)患者中的确切获益尚不清楚。本研究旨在提供关于IOERT作为LACC和LRCC多模式治疗的一部分的现有证据的最新总结。方法本系统评价更新在PROSPERO (CRD42023438184)前瞻性注册。使用Ovid (MEDLINE)、EMBASE、Web of Science和Cochrane Library数据库对2011年7月至2024年4月的研究进行电子文献检索。纳入标准是接受IOERT作为LACC或LRCC多模式治疗的一部分的成年患者。主要终点为5年总生存期(OS)、无病生存期(DFS)和局部控制期(LC)。次要结局包括术后并发症。结果自之前的分析以来,共发现了16项新的研究(研究人群为1912名患者),其中2项为前瞻性研究。高异质性阻碍了结果的荟萃分析,除了5年OS,这表明IOERT的益处不显著。然而,与目前的证据相比,具有R1切除边缘的LACC或LRCC患者的5年总生存率(分别为40%和18%)较好。结论:尽管由于缺乏适当的随机证据,包含ioert的多模式治疗可能改善R1切除的LACC和LRCC患者的肿瘤预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Ejso
Ejso 医学-外科
CiteScore
6.40
自引率
2.60%
发文量
1148
审稿时长
41 days
期刊介绍: JSO - European Journal of Surgical Oncology ("the Journal of Cancer Surgery") is the Official Journal of the European Society of Surgical Oncology and BASO ~ the Association for Cancer Surgery. The EJSO aims to advance surgical oncology research and practice through the publication of original research articles, review articles, editorials, debates and correspondence.
期刊最新文献
Tumour localization and oncological outcomes in nonuterine leiomyosarcoma of the abdomen and pelvis Factors influencing surgical decision-making in breast cancer: A multicenter study in Japan The utility of large language models in oncological multidisciplinary team meetings: A systematic review Global burden, trends, and attributable risk factors of women's cancers with projection to 2050: Results from the GLOBOCAN 2022 and global burden of disease study 2021 Microwave ablation versus surgical resection for hepatocellular carcinoma within Milan criteria: A propensity score–based analysis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1